World J Nucl Med. 2018 Jul-Sep;17(3):151-156. doi: 10.4103/wjnm.WJNM_41_17.

[No title available]

World journal of nuclear medicine

Knut Liepe, Andreas Becker

PMID: 30034278 PMCID: PMC6034543 DOI: 10.4103/wjnm.WJNM_41_17

Abstract

The aim of this study was to assess the potential of

Keywords: 99mTc-Hynic-TOC imaging; neuroendocrine tumor; octreotide; somatostatin receptor

Conflict of interest statement

References

1. Eur J Cancer. 2016 May;58:41-51 - PubMed
2. Surg Oncol Clin N Am. 2016 Apr;25(2):401-21 - PubMed
3. Eur J Nucl Med Mol Imaging. 2006 Sep;33(9):1041-7 - PubMed
4. Nucl Med Rev Cent East Eur. 2016;19(2):99-103 - PubMed
5. J Nucl Med. 2011 Dec;52(12):1864-70 - PubMed
6. J Nucl Med. 2008 Jul;49(7):1060-5 - PubMed
7. Minerva Endocrinol. 2016 Mar;41(1):10-8 - PubMed
8. J Cancer Res Clin Oncol. 1996;122(9):513-32 - PubMed
9. Oncotarget. 2016 Sep 6;7(36):57878-57893 - PubMed
10. Semin Oncol. 1994 Oct;21(5 Suppl 13):15-20 - PubMed
11. Med Sci Monit. 2010 Apr;16(4):MT35-44 - PubMed
12. Eur J Nucl Med Mol Imaging. 2015 Jan;42(1):5-19 - PubMed
13. N Engl J Med. 2017 Jan 12;376(2):125-135 - PubMed
14. Q J Nucl Med Mol Imaging. 2005 Sep;49(3):237-44 - PubMed
15. Endocr Relat Cancer. 2010 Jan 29;17(1):R53-73 - PubMed
16. J Nucl Med. 1995 Apr;36(4):542-9 - PubMed
17. Radiol Med. 2016 Mar;121(3):225-8 - PubMed
18. J Nucl Med. 2014 Oct;55(10):1598-604 - PubMed
19. Int J Cancer. 1992 Apr 1;50(6):895-900 - PubMed
20. J Nucl Med. 2011 Sep;52(9):1474-81 - PubMed
21. J Nucl Med. 2015 Jun;56(6):847-54 - PubMed
22. Eur J Nucl Med. 2000 Jun;27(6):628-37 - PubMed

Publication Types

• Journal Article